Gls Glutaminase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Gls Glutaminase is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Glutaminase | |
|---|---|
| Gene Symbol | GLS |
| Full Name | Glutaminase |
| Chromosome | 2q32.2 |
| NCBI Gene ID | 2745 |
| OMIM | 618484 |
| Ensembl ID | ENSG00000115419 |
| UniProt ID | O94925 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, ALS, Cancer |
GLS (Glutaminase) is an enzyme that hydrolyzes glutamine to glutamate. It is the first step in glutamine metabolism and is important for neurotransmitter synthesis and cancer metabolism[^1].
GLS is a key metabolic enzyme:
GLS performs essential metabolic functions:
GLS may be implicated in AD:
In PD:
GLS is expressed in:
In the brain, GLS is expressed in neurons and astrocytes, supporting glutamate production.
Gls Glutaminase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Gls Glutaminase has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.